The workshop was designed to foster discussion about the FDA’s draft guidance for mobile medical applications and encourage public comment from stakeholders. Specific topics the FDA wanted to address included aspects of the draft guidance. The FDA also sought feedback on how it should approach accessories and standalone software that provide clinical decision support.
Comments on the draft guidance are due by Oct. 19.
Related Articles on Mobile Health Applications:
AMA Names 10 Finalists in App Challenge
Wisconsin’s Gundersen Lutheran, Cincinnati’s St. Elizabeth Healthcare Launch Mobile Apps
Carolinas HealthCare System Develops Mobile App to Improve Access to Care
